Review
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Nov 6, 2023; 11(31): 7508-7520
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7508
Gut microbiome: New perspectives for type 2 diabetes prevention and treatment
Shu-Xiao Li, Yan Guo
Shu-Xiao Li, Yan Guo, School of Clinical Medicine, Changchun University of Traditional Chinese Medicine, Changchun 130000, Jilin Province, China
Author contributions: Li SX analyzed the data, wrote and reviewed the manuscript; Guo Y reviewed the manuscript; all authors have read and approve the final manuscript.
Supported by Jilin Provincial Science and Technology Department, No. 20210204029YY; and Jilin Provincial Natural Science Foundation Projects, No. YDZJ202201ZYTS151.
Conflict-of-interest statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yan Guo, MD, Professor, School of Clinical Medicine, Changchun University of Traditional Chinese Medicine, No. 1035 Boshuo Road, Nanguan District, Changchun 130000, Jilin Province, China. ccguoyan@163.com
Received: August 25, 2023
Peer-review started: August 25, 2023
First decision: September 19, 2023
Revised: September 19, 2023
Accepted: October 23, 2023
Article in press: October 23, 2023
Published online: November 6, 2023
Core Tip

Core Tip: In this review, we summarized the pathogenesis that intestinal flora is involved in type 2 diabetes mellitus (T2DM), as well as therapeutic approaches aimed at modulating the gut microbial for the management of T2DM.